- Volume is elevated versus the 13-week average, confirming attention.
STENO
CPH
Week ended 07 Aug 2026
Weekly Investor Report
Stenocare A/S · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
0.93 DKK
-6.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -19.4% below the Trend Line and sits at 12.2% of its 52-week range. The latest completed week returned -6.4%, after a -6.8% four-week move. The latest news-sentiment score is 50/100.
Setup score
22
out of 100
Latest Close
0.93 DKK
7 Aug 2026
1W Return
-6.4%
latest completed week
4W Return
-6.8%
short-term follow-through
12W Return
-22.0%
quarterly tape
Trend Breadth
55.8%
29 of 52 weeks active
Volume Ratio
1.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-6.4%
Latest completed week; four-week move -6.8%.
Indicator stack
31/9
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.85%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
3 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -19.4% below the Trend Line and sits at 12.2% of its 52-week range. The latest completed week returned -6.4%, after a -6.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.8x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0212-week average 0.03
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.02Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -6.8% over four weeks, -22.0% over 12 weeks, and 26.3% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year29
Trend breadth55.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.69Latest activity-pressure read.
Pressure change-360.9%Four-week change in activity pressure.
Leadership-30.12Latest relative-leadership reading.
RS change-20.2%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 3 relevant articles.
0 positive · 3 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-66.7%Distance below the 52-week high.
13-week volatility3.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2614 weeks finished lower.
Best week+22.1%Week of 27 Mar.
Worst week-16.7%Week of 13 Mar.
Latest week-6.4%Week of 7 Aug.
Shape of recent returns
Strong gains6
Modest gains5
Flat weeks1
Modest losses4
Sharp losses10
Recent vol3.3%13-week weekly-return volatility.
Base vol12.9%52-week weekly-return volatility.
Up/down split23/28Count of positive and negative weeks in the 52-week window.
Average skew11.2% / -7.0%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorDK Healthcare
4-week rank19 / 21
Group average4.0%
Trend breadth28.6%
Trend28.6%active weekly trend signals
MD66.7%positive activity pressure
RS14.3%positive relative leadership
Four-week leaders
IndustryDK Drug Manufacturers - Specialty & Generic
4-week rank3 / 3
Group average-3.7%
Trend breadth66.7%
Trend66.7%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis9/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.02; No reversal markers Next-Week ExpectancyNegative 38.85%Next-week expectancy is negative with a 38.85% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 3 relevant articles.
STENOCARE: Interim report first quarter 2026 Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 0.93 DKK | -6.4% | 1.16 DKK | 2.05 DKK | -0.69 | -30.12 | 408.1K | Off |
| 31 Jul 2026 | 1.00 DKK | 0.8% | 1.18 DKK | 2.07 DKK | -0.42 | -25.00 | 112.1K | Off |
| 24 Jul 2026 | 0.99 DKK | -2.2% | 1.20 DKK | 2.09 DKK | -0.33 | -24.92 | 143.2K | Off |
| 17 Jul 2026 | 1.01 DKK | 1.0% | 1.21 DKK | 2.11 DKK | -0.28 | -25.81 | 204.8K | Off |
| 10 Jul 2026 | 1.00 DKK | -2.0% | 1.23 DKK | 2.13 DKK | -0.15 | -25.06 | 319.0K | Off |
| 3 Jul 2026 | 1.02 DKK | 2.0% | 1.24 DKK | 2.15 DKK | -0.13 | -24.20 | 27.2K | Off |
| 26 Jun 2026 | 1.00 DKK | -8.7% | 1.26 DKK | 2.17 DKK | -0.11 | -21.31 | 97.9K | Off |
| 19 Jun 2026 | 1.09 DKK | 0.5% | 1.29 DKK | 2.19 DKK | -0.17 | -10.49 | 45.4K | Off |
| 12 Jun 2026 | 1.09 DKK | 2.8% | 1.31 DKK | 2.21 DKK | -0.30 | -11.49 | 30.1K | Off |
| 5 Jun 2026 | 1.06 DKK | -4.9% | 1.35 DKK | 2.25 DKK | -0.36 | -12.55 | 428.0K | Off |
| 29 May 2026 | 1.11 DKK | -2.6% | 1.38 DKK | 2.29 DKK | -0.32 | -8.59 | 356.7K | Off |
| 22 May 2026 | 1.15 DKK | -4.2% | 1.39 DKK | 2.33 DKK | -0.49 | -5.15 | 329.6K | Off |
| 15 May 2026 | 1.20 DKK | -1.6% | 1.40 DKK | 2.37 DKK | -0.74 | 1.20 | 469.9K | Off |
| 8 May 2026 | 1.22 DKK | 6.6% | 1.40 DKK | 2.40 DKK | -1.04 | 5.63 | 2.0M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.